NASDAQ:RGC - Nasdaq - KYG7487R1002 - Common Stock - Currency: USD
NASDAQ:RGC (6/30/2025, 1:46:09 PM)
16.3
-1.1 (-6.32%)
The current stock price of RGC is 16.3 USD. In the past month the price decreased by -10.77%. In the past year, price increased by 19578.6%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 56.45 | 736.10B | ||
JNJ | JOHNSON & JOHNSON | 15.12 | 365.58B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 18.66 | 305.88B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.55 | 238.79B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 15.79 | 215.45B | ||
MRK | MERCK & CO. INC. | 10.13 | 198.11B | ||
PFE | PFIZER INC | 7.54 | 137.67B | ||
SNY | SANOFI-ADR | 10.55 | 117.08B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.34 | 94.63B | ||
GSK | GSK PLC-SPON ADR | 8.47 | 77.61B | ||
ZTS | ZOETIS INC | 25.83 | 69.24B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 64.35 | 48.25B |
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
REGENCELL BIOSCIENCE HOLDING
11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
Hong Kong 37918 HK
CEO: Yat-Gai Au
Employees: 12
Phone: 85221550823
The current stock price of RGC is 16.3 USD. The price decreased by -6.32% in the last trading session.
The exchange symbol of REGENCELL BIOSCIENCE HOLDING is RGC and it is listed on the Nasdaq exchange.
RGC stock is listed on the Nasdaq exchange.
REGENCELL BIOSCIENCE HOLDING (RGC) has a market capitalization of 212.06M USD. This makes RGC a Micro Cap stock.
REGENCELL BIOSCIENCE HOLDING (RGC) currently has 12 employees.
REGENCELL BIOSCIENCE HOLDING (RGC) has a support level at 15.66. Check the full technical report for a detailed analysis of RGC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RGC does not pay a dividend.
REGENCELL BIOSCIENCE HOLDING (RGC) will report earnings on 2022-12-13, before the market open.
ChartMill assigns a technical rating of 7 / 10 to RGC. When comparing the yearly performance of all stocks, RGC is one of the better performing stocks in the market, outperforming 100% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to RGC. While RGC has a great health rating, there are worries on its profitability.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -51.07% | ||
ROE | -52.43% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 63% to RGC. The Buy consensus is the average rating of analysts ratings from 12 analysts.